A Case of Sustained Tumor Regression With MP0274, a Novel DARPin Therapeutic Targeting Human Epidermal Growth Factor Receptor 2 Signaling, in Metastatic Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer After Prior Trastuzumab and Pertuzumab.
Stefanie FischerThorsten O GötzeAurelius G OmlinRichard D BairdKeith M DawsonChristof ZittZita AranyGaby TreschUlrike FiedlerSimone JegerSamson FungPhilippe LegenneNicolas LeupinAndreas SchneeweißCarlo FremdPublished in: JCO precision oncology (2022)